Clinical trial
Novel Brominated and Organophosphate Flame Retardants and Type 2 Diabetes
NCT06239506
Study timeline
Study start (actual)2022-01-01Date precision: day
Registry last updated2024-02-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Novel Brominated Flame Retardantsunresolved
Organophosphate Flame Retardantsunresolved
Fasting Plasma Glucoseunresolved
Interventions
no interventionOTHER
Sponsors & collaborators
Xiaoling Guanlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06239506 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.